Back to STATE STREET CORP STATE STREET CORP

CLDXCLDX
Showing 8 of 24 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in CELLDEX THERAPEUTICS INC NEW

STATE STREET CORP holds 3.9M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $145.1M as of 2026-Q2. The position was increased (+39.1% shares). CLDX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$145.1M

Current Shares

3.9M

Total Value Change

+$60.7M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.9M
+39.1%
$145.1M0.0%$37.21
40
2026-Q1
Decreased
2.8M
-17.5%
$88.9M0.0%$31.72
0
2025-Q4
Increased
3.4M
+19.6%
$92.3M0.0%$27.16
35
2025-Q3
Increased
2.8M
+18.1%
$73.5M0.0%$25.87
35
2025-Q2
Decreased
2.4M
-14.3%
$49M0.0%$20.35
0
2025-Q1
Decreased
2.8M
-13.3%
$50.9M0.0%$18.15
0
2024-Q4
Increased
3.2M
+30.2%
$81.7M0.0%$25.27
38
2024-Q3
Decreased
2.5M
-6.5%
$84.5M0.0%$33.99
0

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used